|
Dual-Target Antigen-Selected CAR-NK Clinical Trials
1 actively recruiting trial
Also known as: Cyclophosphamide, EB-SELECT Dual-Target CAR-NK Cells, Fludarabine, IL-2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.